LIMKi3
LIMK inhibitor
Also Known As:
N-(5-(1-(2,6-dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl)-2-thiazolyl)-2-methylpropanamide
Networked: 3
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Barnable, P:
1 article
(01/2022)
|
2. | Mukhopadhyay, S:
1 article
(01/2022)
|
3. | Plagianos, M G:
1 article
(01/2022)
|
4. | Teleshova, N:
1 article
(01/2022)
|
5. | Verma, N:
1 article
(01/2022)
|
6. | Chen, Yeda:
1 article
(07/2021)
|
7. | Duan, Xiaolu:
1 article
(07/2021)
|
8. | Gu, Di:
1 article
(07/2021)
|
9. | Hennenberg, Martin:
1 article
(07/2021)
|
10. | Huang, Ru:
1 article
(07/2021)
|
Related Diseases
Related Drugs and Biologics